248 related articles for article (PubMed ID: 18612077)
1. Differential activation and trafficking of micro-opioid receptors in brain slices.
Arttamangkul S; Quillinan N; Low MJ; von Zastrow M; Pintar J; Williams JT
Mol Pharmacol; 2008 Oct; 74(4):972-9. PubMed ID: 18612077
[TBL] [Abstract][Full Text] [Related]
2. Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine.
Bailey CP; Couch D; Johnson E; Griffiths K; Kelly E; Henderson G
J Neurosci; 2003 Nov; 23(33):10515-20. PubMed ID: 14627635
[TBL] [Abstract][Full Text] [Related]
3. Agonist-specific regulation of mu-opioid receptor desensitization and recovery from desensitization.
Virk MS; Williams JT
Mol Pharmacol; 2008 Apr; 73(4):1301-8. PubMed ID: 18198283
[TBL] [Abstract][Full Text] [Related]
4. Two distinct forms of desensitization of G-protein coupled inwardly rectifying potassium currents evoked by alkaloid and peptide mu-opioid receptor agonists.
Blanchet C; Sollini M; Lüscher C
Mol Cell Neurosci; 2003 Oct; 24(2):517-23. PubMed ID: 14572471
[TBL] [Abstract][Full Text] [Related]
5. Neurokinin 1 receptors regulate morphine-induced endocytosis and desensitization of mu-opioid receptors in CNS neurons.
Yu YJ; Arttamangkul S; Evans CJ; Williams JT; von Zastrow M
J Neurosci; 2009 Jan; 29(1):222-33. PubMed ID: 19129399
[TBL] [Abstract][Full Text] [Related]
6. Mu opioid receptor-effector coupling and trafficking in dorsal root ganglia neurons.
Walwyn WM; Wei W; Xie CW; Chiu K; Kieffer BL; Evans CJ; Maidment NT
Neuroscience; 2006 Oct; 142(2):493-503. PubMed ID: 16887280
[TBL] [Abstract][Full Text] [Related]
7. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.
Narita M; Suzuki M; Narita M; Niikura K; Nakamura A; Miyatake M; Yajima Y; Suzuki T
Neuroscience; 2006; 138(2):609-19. PubMed ID: 16417975
[TBL] [Abstract][Full Text] [Related]
8. Does PKC activation increase the homologous desensitization of μ opioid receptors?
Arttamangkul S; Birdsong W; Williams JT
Br J Pharmacol; 2015 Jan; 172(2):583-92. PubMed ID: 24697621
[TBL] [Abstract][Full Text] [Related]
9. p38 MAPK and beta-arrestin 2 mediate functional interactions between endogenous micro-opioid and alpha2A-adrenergic receptors in neurons.
Tan M; Walwyn WM; Evans CJ; Xie CW
J Biol Chem; 2009 Mar; 284(10):6270-81. PubMed ID: 19126537
[TBL] [Abstract][Full Text] [Related]
10. Involvement of PKC alpha and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of mu-opioid receptors in mature brain neurons.
Bailey CP; Oldfield S; Llorente J; Caunt CJ; Teschemacher AG; Roberts L; McArdle CA; Smith FL; Dewey WL; Kelly E; Henderson G
Br J Pharmacol; 2009 Sep; 158(1):157-64. PubMed ID: 19309357
[TBL] [Abstract][Full Text] [Related]
11. Morphine-induced trafficking of a mu-opioid receptor interacting protein in rat locus coeruleus neurons.
Jaremko KM; Thompson NL; Reyes BA; Jin J; Ebersole B; Jenney CB; Grigson PS; Levenson R; Berrettini WH; Van Bockstaele EJ
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():53-65. PubMed ID: 24333843
[TBL] [Abstract][Full Text] [Related]
12. Opioid agonists differentially regulate mu-opioid receptors and trafficking proteins in vivo.
Patel MB; Patel CN; Rajashekara V; Yoburn BC
Mol Pharmacol; 2002 Dec; 62(6):1464-70. PubMed ID: 12435815
[TBL] [Abstract][Full Text] [Related]
13. Prolonged morphine treatment alters δ opioid receptor post-internalization trafficking.
Ong EW; Xue L; Olmstead MC; Cahill CM
Br J Pharmacol; 2015 Jan; 172(2):615-29. PubMed ID: 24819092
[TBL] [Abstract][Full Text] [Related]
14. Prolonged stimulation of μ-opioid receptors produces β-arrestin-2-mediated heterologous desensitization of α(2)-adrenoceptor function in locus ceruleus neurons.
Dang VC; Chieng BC; Christie MJ
Mol Pharmacol; 2012 Sep; 82(3):473-80. PubMed ID: 22689562
[TBL] [Abstract][Full Text] [Related]
15. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
[TBL] [Abstract][Full Text] [Related]
16. Agonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization.
Chu J; Zheng H; Zhang Y; Loh HH; Law PY
Cell Signal; 2010 Apr; 22(4):684-96. PubMed ID: 20043990
[TBL] [Abstract][Full Text] [Related]
17. Functional selectivity and time-dependence of μ-opioid receptor desensitization at nerve terminals in the mouse ventral tegmental area.
Lowe JD; Bailey CP
Br J Pharmacol; 2015 Jan; 172(2):469-81. PubMed ID: 24467517
[TBL] [Abstract][Full Text] [Related]
18. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
Yoburn BC; Purohit V; Patel K; Zhang Q
Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
[TBL] [Abstract][Full Text] [Related]
19. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
20. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
